In Private Practice

• Lead and co-lead counsel in defense of multiple publicly-traded companies in high-profile FCPA resolutions of DOJ, SEC, and overseas investigations involving conduct in the Bahamas, Brazil, Egypt, Equatorial Guinea, Germany, Ghana, Indonesia, Saudi Arabia, South Africa, Switzerland, Taiwan, and other countries.
• Lead and co-lead counsel conducting internal investigations for multiple public and non-public companies into possible FCPA violations in Argentina, Brazil, China, Qatar, Malaysia, Mexico, Thailand, Venezuela, and other countries.
• Lead and co-lead counsel securing declinations from DOJ and/or SEC in FCPA investigations involving conduct in Afghanistan, Brazil, China, and other countries.
• Lead and co-lead counsel representing companies based in the U.S., Brazil, France, and Switzerland in connection with worldwide anti-corruption compliance monitorships and self-monitorships imposed as part of the resolution of FCPA investigations.
• Lead counsel representing numerous executives and employees individually in DOJ and SEC investigation of alleged FCPA violations.
• Lead counsel representing founder of private company in investigations by DOJ and the Department of Commerce (BIS) for alleged export violations.
• Lead counsel representing a reporter subpoenaed by the DOJ for testimony and documents identifying confidential sources.
• Lead counsel representing employees of private equity company in DOJ and SEC investigation of alleged accounting fraud.
• Counsel to board of directors of a publicly-traded company in connection with DOJ and SEC investigations of alleged FCPA violations in Mexico.
• Co-lead counsel representing a company under investigation for alleged violations of the False Claims Act.
• Co-lead counsel representing the board of directors of a hospice company under investigation for alleged violations of the False Claims Act.
• Lead counsel representing a current executive of a pharmaceutical company under investigation for alleged violations of the False Claims Act based on kickbacks and off-label marketing.
• Lead counsel representing a former executive of a hospital company under investigation for alleged violations of the False Claims Act.
• Lead counsel representing current and former executives of a dialysis company under investigation for alleged violations of the False Claims Act.
• Counsel in defense of a hospital and physicians in a federal civil False Claims Act case alleging fraudulent Medicare billings and whistleblower retaliation.
• Co-lead counsel representing a congressional campaign committee in connection with the DOJ’s and the Federal Elections Commission’s (FEC) investigations of embezzlement by a former campaign treasurer.
• Counsel representing a member of Congress in an investigation by the Office of Congressional Ethics (OCE).
• Counsel in defense of a former controller of a publicly-traded company in an accounting and securities fraud investigation.
• Co-trial counsel in a civil fraud and conspiracy action against corporate and individual defendants resulting in an $8 million jury verdict in favor of client.

In Government

• Lead counsel in the prosecution of worldwide FCPA violations by a non-U.S. company resulting in corporate deferred prosecution agreements, corporate guilty pleas, combined criminal and civil penalties of $185 million, and a three-year monitorship of the parent company’s FCPA compliance program and related internal controls, and books and records.
• Co-lead counsel in an investigation of allegations of fraud in connection with post-disaster claims under the National Flood Insurance Program.
• Lead prosecutor in Medicare Fraud Strike Force take-downs of over 45 health care fraud defendants, and in charge of supervising investigations, grand jury presentations, plea negotiations, and trials.
• Lead counsel in an investigation of nationwide anti-kickback violations by the sales force of a publicly-traded pharmaceutical company.
• Co-counsel in an investigation of allegations of FCPA violations by a non-U.S. based company, working with the U.K.’s Serious Fraud Office.

Matters may have been completed before joining Paul Hastings.

Mr. Darden is a frequent writer and speaker on white-collar issues. Recent speaking engagements and articles include:

• “FCPA Whistleblowers – Perspectives from the Defense and Plaintiffs,” PLI (2023)
• “Financial Crimes,” International Law Institute (2022)
• Co-author, “Brazil’s Five-Year Anti-Corruption Plan: Takeaways for In-House Counsel and Anti-Corruption Lawyers,” Anti-Corruption Report (2021)
• “Anti-Corruption Enforcement Proceedings in Brazil and the U.S.,” Brazil-US Under 40 White Collar Initiative (2021)
• “Brazil’s Rising Enforcement and Fine Regime,” Forensic Risk Alliance Webinar (2021)
• “Ethical Leadership and Economic Development: Ethics in Monitorships,” Laboratório Internacional do ComplianceLab (2020)
• “Challenges and Opportunities: Views from the Defense Perspective,” Latin Lawyer-GIR Interactive Anti-Corruption & Investigations (2020)
• “The Prosecutor’s Perspective: Interactive Compliance Seminar,” International Anti-Corruption Academy (2019)
• “Anti-Corruption Panel Discussion,” ABA International Section Conference (2019)

• Past member, Law360 White Collar Editorial Advisory Board
• Past member, Alumni Council, Washington & Lee University/Williams School
• Class Manager, University of Virginia/School of Law